FIELD: medicine, pulmonology, allergy, pharmacy. SUBSTANCE: invention proposes composition for treatment of lung inflammatory diseases, among them, bronchial asthma. The composition comprising budesonide and water contains additionally propylene glycol, polyethylene oxide, succinic acid, Trilon B, nipagin in the following ratio of components, wt.-%: budesonide, 0.01-0.1; propylene glycol, 10.0-25.0; polyethylene oxide, 30.0-40.0; succinic acid, 0.05-0.5; Trilon B, 0.01-0.1; nipagin, 0.01-0.1; water up to 100.0. The composition can comprise additionally 6-(acetylamino)-hexanoic acid taken in the amount from 0.0% to 5% and polyethylene oxide-400 as polyethylene oxide. The composition can be used for inhalation. EFFECT: enhanced stability, reduced toxicity of composition. 4 cl
| Title | Year | Author | Number |
|---|---|---|---|
| STABLE BUDESONIDE-CONTAINING AQUEOUS SOLUTION WITH ANTI-INFLAMMATORY EFFECT | 2000 |
|
RU2180217C2 |
| CYCLOPHERONE-BASED PHARMACEUTICAL COMPOSITION OF LOCAL OR EXTERNAL APPLICATION FOR TREATMENT OF PURULENT-DESTRUCTIVE AFFECTION OF MUCOUS MEMBRANE AND SKIN, GENERAL-SYSTEM DISEASES IN CASE OF IMMUNODEFICIENCY CONDITIONS (VERSIONS) | 2008 |
|
RU2414221C2 |
| PHARMACEUTICAL COMPOSITION OF METERED AEROSOLS CONTAINING ANTIASTHMATIC AGENTS IN FORM OF SUSPENSIONS, SOLUTIONS, EMULSIONS, SOLUTIONS AND EMULSIONS | 2007 |
|
RU2356537C2 |
| LOCAL AND EXTERNAL PHARMACEUTICAL PRODUCT BASED OF LOW MOLECULAR INTERFERON INDUCER | 2007 |
|
RU2353354C1 |
| TOPICAL AND EXTERNAL TILORONE PHARMACEUTICAL COMPOSITION FOR TREATMENT OF PURULENT-DESTRUCTIVE MUCOSAL AND SKIN DISEASES, SYSTEMIC DISEASES IN IMMUNODEFICIENCY STATES | 2008 |
|
RU2401104C2 |
| PHARMACEUTICAL PREPARATION FOR LOCAL AND EXTERNAL USE, BASED ON LOW-MOLECULAR INTERFERON INDUCER | 2007 |
|
RU2348400C1 |
| INHALATION COMPOSITION FOR TREATMENT OF BRONCHIAL ASTHMA | 2002 |
|
RU2242972C2 |
| PHARMACEUTICAL COMBINED COMPOSITION FOR THE TREATMENT OF PURULENT WOUNDS ON THE BASIS OF FLUOROQUINOLONS (OPTIONS) | 2016 |
|
RU2682171C2 |
| PHARMACEUTICAL COMBINED COMPOSITION FOR LOCAL AND EXTERNAL USE ON BASIS OF DIOXIDINE | 2016 |
|
RU2667974C2 |
| EXTERNAL AND LOCAL PHARMACEUTICAL STEPHAGLABRIN PREPARATION | 2007 |
|
RU2364399C1 |
